Frontiers in Immunology (Oct 2022)
The IgG glycome of SARS-CoV-2 infected individuals reflects disease course and severity
- Sterre L. Siekman,
- Tamas Pongracz,
- Wenjun Wang,
- Jan Nouta,
- Peter G. Kremsner,
- Peter G. Kremsner,
- Peter G. Kremsner,
- Pedro Vieira da Silva-Neto,
- Meral Esen,
- Meral Esen,
- Meral Esen,
- Andrea Kreidenweiss,
- Andrea Kreidenweiss,
- Andrea Kreidenweiss,
- Jana Held,
- Jana Held,
- Jana Held,
- Átila Alexandre Trapé,
- Rolf Fendel,
- Rolf Fendel,
- Rolf Fendel,
- Isabel Kinney Ferreira de Miranda Santos,
- Manfred Wuhrer,
- ImmunoCovid Consortium,
- Alessandro P. de Amorim,
- Jamille G M. Argolo,
- Rita de C.C. Barbieri,
- Marcelo Dias-Baruffi,
- Victor A F. Bastos,
- Vânia L D. Bonat,
- Cristina Ribeiro de Barros Cardoso,
- Ingryd Carmona-Garcia,
- Jonatan C S de Carvalho,
- Leticia F. Constant,
- Augusto M. Degiovani,
- Cassia F.S.L. Dias,
- Lúcia H. Faccioli,
- Marley R. Feitosa,
- Omar Feres,
- Ana Paula Morais Fernandes,
- Talita M. Fernandes,
- Thais F C. Fraga-Silva,
- Carlos Fuzo,
- Isabelle C. Guarneri,
- Cristiane M. Milanezi,
- Caroline T. Garbato,
- Gilberto Gambero Gaspar,
- Ângelo A.F. Júnior,
- Sandra R. Maruyama,
- Debora C. Nepomuceno,
- Nicola T. Neto,
- Camilla Narjara Simão Oliveira,
- Fátima M. Ostini,
- Rogerio S. Parra,
- Malena M. Pérez,
- Vinı́cius E. Pimentel,
- Giovanna da S. Porcel,
- José J R da Rocha,
- Lilian C. Rodrigues,
- Elisa M S. Russo,
- Dayane P. da Silva,
- Rafael C. da Silva,
- Carlos Arterio Sorgi,
- Camila O S. Souza,
- Diana M. Toro,
- Angelina L. Viana,
- Fernando Crivelenti Vilar,
- Ana C. Xavier,
- Kamila Zaparoli
Affiliations
- Sterre L. Siekman
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands
- Tamas Pongracz
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands
- Wenjun Wang
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands
- Jan Nouta
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands
- Peter G. Kremsner
- Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany
- Peter G. Kremsner
- Centre de Recherches Medicales de Lambaréné, Lambaréné, Gabon
- Peter G. Kremsner
- German Center for Infection Research, Deutschen Zentrum für Infektionsforschung (DZIF), Partner Site Tübingen, Tübingen, Germany
- Pedro Vieira da Silva-Neto
- School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, São Paulo, Brazil
- Meral Esen
- Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany
- Meral Esen
- Centre de Recherches Medicales de Lambaréné, Lambaréné, Gabon
- Meral Esen
- German Center for Infection Research, Deutschen Zentrum für Infektionsforschung (DZIF), Partner Site Tübingen, Tübingen, Germany
- Andrea Kreidenweiss
- Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany
- Andrea Kreidenweiss
- Centre de Recherches Medicales de Lambaréné, Lambaréné, Gabon
- Andrea Kreidenweiss
- German Center for Infection Research, Deutschen Zentrum für Infektionsforschung (DZIF), Partner Site Tübingen, Tübingen, Germany
- Jana Held
- Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany
- Jana Held
- Centre de Recherches Medicales de Lambaréné, Lambaréné, Gabon
- Jana Held
- German Center for Infection Research, Deutschen Zentrum für Infektionsforschung (DZIF), Partner Site Tübingen, Tübingen, Germany
- Átila Alexandre Trapé
- School of Physical Education and Sport of Ribeirão Preto, University of São Paulo, São Paulo, Brazil
- Rolf Fendel
- Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany
- Rolf Fendel
- Centre de Recherches Medicales de Lambaréné, Lambaréné, Gabon
- Rolf Fendel
- German Center for Infection Research, Deutschen Zentrum für Infektionsforschung (DZIF), Partner Site Tübingen, Tübingen, Germany
- Isabel Kinney Ferreira de Miranda Santos
- Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil
- Manfred Wuhrer
- Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands
- ImmunoCovid Consortium
- Alessandro P. de Amorim
- Jamille G M. Argolo
- Rita de C.C. Barbieri
- Marcelo Dias-Baruffi
- Victor A F. Bastos
- Vânia L D. Bonat
- Cristina Ribeiro de Barros Cardoso
- Ingryd Carmona-Garcia
- Jonatan C S de Carvalho
- Leticia F. Constant
- Augusto M. Degiovani
- Cassia F.S.L. Dias
- Lúcia H. Faccioli
- Marley R. Feitosa
- Omar Feres
- Ana Paula Morais Fernandes
- Talita M. Fernandes
- Thais F C. Fraga-Silva
- Carlos Fuzo
- Isabelle C. Guarneri
- Cristiane M. Milanezi
- Caroline T. Garbato
- Gilberto Gambero Gaspar
- Ângelo A.F. Júnior
- Sandra R. Maruyama
- Debora C. Nepomuceno
- Nicola T. Neto
- Camilla Narjara Simão Oliveira
- Fátima M. Ostini
- Rogerio S. Parra
- Malena M. Pérez
- Vinı́cius E. Pimentel
- Giovanna da S. Porcel
- José J R da Rocha
- Lilian C. Rodrigues
- Elisa M S. Russo
- Dayane P. da Silva
- Rafael C. da Silva
- Carlos Arterio Sorgi
- Camila O S. Souza
- Diana M. Toro
- Angelina L. Viana
- Fernando Crivelenti Vilar
- Ana C. Xavier
- Kamila Zaparoli
- DOI
- https://doi.org/10.3389/fimmu.2022.993354
- Journal volume & issue
-
Vol. 13
Abstract
Immunoglobulin G (IgG) antibodies play an important role in the immune response against viruses such as SARS-CoV-2. As the effector functions of IgG are modulated by N-glycosylation of the Fc region, the structure and possible function of the IgG N-glycome has been under investigation in relation to divergent COVID-19 disease courses. Through LC-MS analysis we studied both total IgG1 and spike protein-specific IgG1 Fc glycosylation of 129 German and 163 Brazilian COVID-19 patients representing diverse patient populations. We found that hospitalized COVID-19 patients displayed decreased levels of total IgG1 bisection and galactosylation and lowered anti-S IgG1 fucosylation and bisection as compared to mild outpatients. Anti-S IgG1 glycosylation was dynamic over the disease course and both anti-S and total IgG1 glycosylation were correlated to inflammatory markers. Further research is needed to dissect the possible role of altered IgG glycosylation profiles in (dys)regulating the immune response in COVID-19.
Keywords